Pseudomyxoma peritonei: a review of 62 cases

被引:53
作者
van Ruth, S
Acherman, YIZ
van de Vijvert, MJ
Hart, AAM
Verwaal, VJ
Zoetmulder, FAN
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg Oncol, NL-1066 CX Amsterdam, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[3] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, NL-1066 CX Amsterdam, Netherlands
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 2003年 / 29卷 / 08期
关键词
pseudomyxoma peritonei; pathology; HIPEC; disseminated peritoneal adenomucinosis; peritoneal mucinous carcinomatosis with intermediate or discordant features;
D O I
10.1016/S0748-7983(03)00149-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Pseudomyxoma peritonei (PMP) is a rare disease characterized by the abundance of mucus in the abdomen without extra-peritoneal growth. Methods: Our patients with PMP have been treated with cytoreduction and hyperthermic intraperitoneal chemotherapy since 1996. The clinical and histopathological features of PMP and the relation of these features with disease-free interval and survival were assessed. Results: Sixty-two patients with PMP (24 M/38 F) were studied. Adenomatous mucosal changes were present in 31 patients. In females, the ovaries were normal in 5 patients and pseudomyxoma ovarii was present in 20 patients. Patients with minimal atypia and with 1% focal proliferation or less (n = 38) had a better survival (p = 0.0008) than those with more focal proliferation (n = 14). Conclusion: In most patients with PMP the appendix is affected; in females the ovaries are usually also involved. Focal proliferation appears to be a prognostic factor. (C) 2003 Published by Elsevier Ltd.
引用
收藏
页码:682 / 688
页数:7
相关论文
共 28 条
[1]  
CHEVILLOTTE G, 1983, GASTROEN CLIN BIOL, V7, P445
[2]  
de Bree E, 2000, J SURG ONCOL, V75, P270
[3]  
Elias D, 2001, CANCER, V92, P71, DOI 10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO
[4]  
2-9
[5]  
Hinson FL, 1998, BRIT J SURG, V85, P1332
[6]  
Jacquet P, 1998, CANCER CHEMOTH PHARM, V41, P147
[7]  
Katano K, 2000, ANTICANCER RES, V20, P1603
[8]  
KREISSIG P, 1991, PRESSE MED, V20, P1287
[9]   PSEUDOMYXOMA PERITONEI DUE TO ADENOCARCINOMA OF THE LUNG - CASE-REPORT [J].
KURITA, M ;
KOMATSU, H ;
HATA, Y ;
SHIINA, S ;
OTA, S ;
TERANO, A ;
SUGIMOTO, T ;
OKA, T ;
NANBA, Y .
JOURNAL OF GASTROENTEROLOGY, 1994, 29 (03) :344-348
[10]  
MARKMAN M, 1991, SEMIN ONCOL, V18, P248